Nixon Peabody
Pac Premier
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen gets FDA approval for migraine drug Aimovig

By   /   Thursday, May 17th, 2018  /   Comments Off on Amgen gets FDA approval for migraine drug Aimovig

    Print       Email
Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 17 for its new monthly migraine treatment Aimovig. “Migraine is a serious neurological disease that has dramatic effects on patients’ lives,” Sean Harper, executive vice president of research and development, said in a news release. “Migraine patients experience excruciating headache pain,…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Henry Dubroff

Dubroff: After a decade ruled by tech, value stocks could make a comeback

Read More →